Evidence map›Paper›PMID 32742371›Full record

ArticleExperimental and therapeutic medicine2020

Integrative transcriptomics and metabolomics analyses provide hepatotoxicity mechanisms of asarum.

Sa Cao, Lintao Han, Yamin Li, Shiqi Yao, Shuaihong Hou, Shi-Shi Ma, Wangqiang Dai, Jingjing Li, Zhenxiang Zhou, Qiong Wang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Efficacy and safety ofAnnals of translational medicine · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sa CaoDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Lintao HanDepartment of Chinese Medicine Resource and Compound Prescription, Ministry of Education, Wuhan, Hubei 430065, P.R. China.
Yamin LiDepartment of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, P.R. China.
Shiqi YaoDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Shuaihong HouDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Shi-Shi MaDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Wangqiang DaiDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Jingjing LiDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Zhenxiang ZhouDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Qiong WangDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Fang HuangDepartment of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Hubei University of Chinese Medicine · CNFirst Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asarum is frequently applied in combination with other agents for prescriptions in practices of Traditional Chinese Medicine. A number of studies have previously indicated that asarum treatment induces lung toxicity by triggering inflammation. However, the potential effects of asarum in the liver and the underlying mechanisms have remained largely elusive. Therefore, transcriptomics and metabolomics approaches were used in the present study to examine the mechanisms of the hepatotoxicity of asarum. Specifically, mRNA and metabolites were obtained from rat liver samples following intragastric administration of asarum powder. RNA sequencing analysis was subsequently performed to screen for differentially expressed genes (DEGs), and a total of 434 DEGs were identified in liver tissue samples, 214 of which were upregulated and 220 were downregulated. Pathway enrichment analysis found that these genes were particularly enriched in processes including the regulation of p53 signaling, metabolic pathways and bile secretion. To investigate potential changes to the metabolic profile as a result of asarum treatment, a metabolomics analysis was performed, which detected 14 significantly altered metabolites in rat liver samples by gas chromatography-mass spectrometry. These metabolites were predominantly members of the taurine, hypotaurine and amino acid metabolic pathways. Metscape network analyses were subsequently performed to integrate the transcriptomics and metabolomics data. Integrative analyis revealed that the DEGs and metabolites were primarily associated with bile acid biosynthesis, amino acid metabolism and the p53 signaling pathway. Taken together, these results provide novel insight into the mechanism of asarum-mediated hepatotoxicity, which may potentially aid the clinical diagnosis and future therapeutic intervention of asarum poisoning.

Indexed as

asarumhepatotoxicityintegrationmetabolomicstranscriptomics

Identifiers

PMID32742371
PMCPMC7388312
OpenAlexW3028596657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.